comparemela.com
Home
Live Updates
Dr Kantarjian on the Predictive Value of Early Responses to Ponatinib in CP-CML : comparemela.com
Dr Kantarjian on the Predictive Value of Early Responses to Ponatinib in CP-CML
Hagop M. Kantarjian, MD, discusses the predictive value of early landmark cytogenetic or molecular responses to ponatinib in heavily pretreated patients with chronic-phase chronic myeloid leukemia.
Related Keywords
Texas ,
United States ,
Hagopm Kantarjian ,
,
Department Of Leukemia ,
University Of Texas Md Anderson Cancer Center ,
Samsung Distinguished Leukemia Chair ,
Cancer Medicine ,
Cancer Center ,
Soho Annual Meeting ,
Soho 2023 ,
Cp Cml ,
Ncml ,
Ponatinib ,
comparemela.com © 2020. All Rights Reserved.